More focus on new drug projects, experts say

Korea should seek to expand its spending in research and development (R&D) as part of efforts to cope with in the era of free trade agreements (FTAs), experts point out.

They emphasize that the government should strive to draft a set of measures to bring a paradigm shift to the local pharmaceutical industry - from duplicators of generic drugs to new medicine creators.

Thus far, domestic c...